Yabao Pharmaceutical announced on August 7 that the company signed a technology transfer agreement for new traditional Chinese medicine projects with Shanxi University on August 6, transferring the clinical trial approval documents, patent rights, and related technical information. of the Class 6.1

1. PatentFrom January to July 2023, the number of authorized invention patents in China was515,000, the number of authorized utility model patents was1.254 million, and the number of authorized design patents was383,000.As of the end of July 2023, the number of valid invention patents in China is 4.

The two-year patent war between Contemporary Amperex Technology Co., Limited（CATL）and CALB has reversed.On the evening of August 3, CALB announced that the CNIPA had issued two "Examination Decision on Request for Invalidation", respectively claiming the "lithium-ion battery" and "positive electrode

On July 24, it’s reported by CCTV News today that at the 2023 China Automobile Innovation Conference held on July 23, China Automobile Technology and Research Center Co., Ltd. and Peking University jointly released the "Blue Paper on Automotive Standard Essential Patents", which is China’s first sys

Recently, CNIPA issued its Decision on the Awarding of the 24th China Patent Award. The invention patent "EGFR Inhibitor and Preparation and Application Thereof" (Patent No.: ZL 201580045311.2) for the innovative drug Ameile (Aumolertinib Mesylate Tablets) developed by Hansoh Pharma, won the 24th Ch